Enecadin

• Description:

  Enecadin is a neuroprotective agent extracted from patent US 8623823 B2.

• UNSPSC:

  12352005

• Target:

  Calcium Channel

• Type:

  Reference compound

• Related Pathways:

  Membrane Transporter/Ion Channel; Neuronal Signaling

• Applications:

  COVID-19-immunoregulation

• Field of Research:

  Neurological Disease; Cardiovascular Disease

• Assay Protocol:

  https://www.medchemexpress.com/Enecadin.html

• Concentration:

  10mM

• Purity:

  98.51

• Solubility:

  DMSO : ≥ 50 mg/mL

• Smiles:

  CC1=NC(OCCCCCN2CCCCC2)=CC(C3=CC=C(F)C=C3)=N1

• Molecular Formula:

  C21H28FN3O

• Molecular Weight:

  357.46

• References & Citations:

  [1]Anil Gulati. Methods for treatment of stroke or cerebrovascular accidents using an ETB receptor agonist. US 8623823 B2.

• Shipping Conditions:

  Room Temperature

• Storage Conditions:

  -20°C, 3 years; 4°C, 2 years (Powder)

• Scientific Category:

  Reference compound1

• Clinical Information:

  Phase 2

• CAS Number:

  [259525-01-4]